MIT SENIOR RESEARCHER, YUMING LIU, JOINS ATMOFIZER AS SCIENTIFIC ADVISOR
Yuming Liu is joining Atmofizer Technologies Inc. in the capacity of scientific adviser. Mr. Liu is a senior researcher at the Massachusetts Institute of Technology (MIT) and an expert in sound wave technology and water.
Mr. Liu was co-author of a study by researchers in MIT's Department of Mechanical Engineering that suggests coronaviruses may be vulnerable to ultrasound vibrations, within the frequencies used in medical diagnostic imaging, as reported in March, 2021, by MIT News.
"We are honoured to be working with Yuming. His expertise is a tremendous addition to our scientific team, and his involvement is a testament to our technology and the opportunity it brings to the entire industry," said Olivier Centner, chief executive officer of Atmofizer. "Yuming will help to both develop our applications for clean air but also to begin our work on applying our technology to water purification."
"I am excited to work with Atmofizer and further their development and research. The Atmofizer technology brings a fresh approach to purifying air and water," said Mr. Liu. "This is a great opportunity to work on a practical solution to the paper I wrote on ultrasonics being able to destroy COVID. The progress we are making on air purification is very exciting, and I am excited to get started on adapting the same to water."
MIT News reported that the results of the study are preliminary and based on limited data regarding the virus's physical properties. MIT News further reported that how ultrasound could be administered and how effective it would be in damaging the virus within the complexity of the human body would require further study. Atmofizer was not a party to, nor financed any of MIT's or Mr. Liu's research. The study is included in this news release for informative purposes only.
About Atmofizer Technologies Inc.
Atmofizer's consumer and industrial solutions are based on its patent-protected and patent-pending technology for ultrafine particle agglomeration and neutralization. This capability creates a revolutionary and more efficient method for addressing the wide range of dangerous nano-scale particles, viruses and bacteria that are too small to be effectively managed by conventional HEPA (high-efficiency particulate absorbing) filters and ultraviolet lights. Atmofizer plans to disrupt the air treatment industry by improving air safety and purification efficiency while lowering customers' operational costs.
Atmofizing air refers to the process of using ultrasonic acoustic waves to agglomerate (cluster together) small particles into a larger target that is then radiated by ultraviolet light to neutralize their harmful properties, making the air you breathe less hazardous to your health. Using units that atmofize air in tandem with HEPA filters can make the HEPA filters work more efficiently, enable the use of a less powerful filter, and result in a cleaner and longer-lasting filter that reduces operating costs and is less of a health hazard to clean or replace.
Atmofizer is patent-pending and patent-protected sole source of technology to atmofize air, and is applying its proprietary technology in consumer and industrial air purification products currently manufactured under the Atmofizer brand, as well as in retail and commercial devices produced by other companies that integrate Atmofizer technology into their own products under licence. Atmofizer's owned and licensed product lines include wearable, portable and mobile use for personal air treatment, as well as larger systems to handle higher air volumes for commercial, industrial, institutional and residential applications.